Boiler Room: The Official Stock Market Discussion

Bernie Madoff

Banned
Joined
Jun 23, 2012
Messages
11,925
Reputation
-2,414
Daps
18,686
Reppin
Otisville, Federal Correctional Institution
News from this past Thursday..

http://finance.yahoo.com/news/dynavax-progresses-heplisav-173004096.html

Dynavax Technologies Corporation (DVAX) received encouraging news when the design of its next large-scale clinical study on its hepatitis B vaccine candidate, Heplisav, was finalized following discussions with the U.S. Food and Drug Administration (:FDA).

We remind investors that Dynavax suffered a setback in Jun 2013 when the FDA asked for additional safety data on Heplisav. The company had conducted a meeting with the agency to discuss the complete response letter (CRL) received earlier this year for the Heplisav Biologic License Application (:BLA).

The FDA had then stated that the database needed additional subjects as analyzing the safety profile on the current database would probably lead to an approval for a limited population thereby preventing additional patients to benefit from the treatment if approved. The collection of data on a broader population will facilitate review of the indication in adults in the age bracket of 18-70.
 

Bernie Madoff

Banned
Joined
Jun 23, 2012
Messages
11,925
Reputation
-2,414
Daps
18,686
Reppin
Otisville, Federal Correctional Institution
Dvax currently trading at 1.27
Support 2= 1.24
Support 1= 1.21

Pivot= 1.28

Resistance 1= 1.31
Resistance 2= 1.35

50 day moving average= 1.25
200 day moving average = 1.83

Perfectly posistioned to enter here IMO. As I said before the April 19 $1 calls .50 Buying some common isn't a bad idea but I'm going to look to flip some of the calls on a spike between .65-.85
Probably can get .65 if DVAX hits 1.50 on a day with high volume.

It's trading pretty consistently around the 50 day moving average and IMO the only way it's going to break 1.21 is on some unforeseen negative catalyst. All the news that is going to drive this stuck down though is already out from the research I've done. Plenty of catalyst for a spike.
 
Last edited:

Bernie Madoff

Banned
Joined
Jun 23, 2012
Messages
11,925
Reputation
-2,414
Daps
18,686
Reppin
Otisville, Federal Correctional Institution
I feel like bio-techs respond more to catalysts than TA.
I look at each stock independently to gauge risk. Since all the negative news is out, I feel by showing the 50 day moving average of Dvax, it shows the stock has found it's bottom in this area. Something can always come out of nowhere but I don't see it.
http://stockcharts.com/h-sc/ui?s=Dvax
 
Last edited:

loki

Pro
Joined
May 3, 2012
Messages
606
Reputation
1,640
Daps
690
Reppin
#Byrdgang
I look at each stock independently to gauge risk. Since all the negative news is out, I feel by showing the 50 day moving average of Dvax, it shows the stock has found it's bottom in this area. Something can always come out of nowhere but I don't see it.
http://stockcharts.com/h-sc/ui?s=Dvax

Im new to this so I apologize if this is a dumb question. In your opinion is this something that someone should invest in? If so, would it be better to buy stocks or options?
 

Bernie Madoff

Banned
Joined
Jun 23, 2012
Messages
11,925
Reputation
-2,414
Daps
18,686
Reppin
Otisville, Federal Correctional Institution
Im new to this so I apologize if this is a dumb question. In your opinion is this something that someone should invest in? If so, would it be better to buy stocks or options?
In my opinon yes. I would those April $1 calls for .50 are the way to go. It's not going to an exciting stock to own, as its been trading sideways. But I expect some positive catalyst to come out within 6 months.. I would like to sell some calls back at .65. Play with house money.
 

Mr swag

We Out Here
Joined
Apr 30, 2012
Messages
17,813
Reputation
-1,680
Daps
31,048
Reppin
The Well Respected Uptown,Virginia
Dvax currently trading at 1.27
Support 2= 1.24
Support 1= 1.21

Pivot= 1.28

Resistance 1= 1.31
Resistance 2= 1.35

50 day moving average= 1.25
200 day moving average = 1.83

Perfectly posistioned to enter here IMO. As I said before the April 19 $1 calls .50 Buying some common isn't a bad idea but I'm going to look to flip some of the calls on a spike between .65-.85
Probably can get .65 if DVAX hits 1.50 on a day with high volume.

It's trading pretty consistently around the 50 day moving average and IMO the only way it's going to break 1.21 is on some unforeseen negative catalyst. All the news that is going to drive this stuck down though is already out from the research I've done. Plenty of catalyst for a spike.

how high do u think this stock can go????
 

Bernie Madoff

Banned
Joined
Jun 23, 2012
Messages
11,925
Reputation
-2,414
Daps
18,686
Reppin
Otisville, Federal Correctional Institution
how high do u think this stock can go????
If the FDA approves the drug 5+ pretty quickly.
As I keep stating, once any information comes out that a FDA decsion is likely to come it will run the price to 2+with high volume imo. It's going to be a boring stock to own though. They do have this news in the 1q of 2014
Meanwhile, Dynavax has also submitted Heplisav for review in Europe. Dynavax is currently preparing its response to the European Medicines Agency's (:EMA) 120-Day List of Questions which is required to be submitted in the fourth quarter of 2013. Thereafter, Dynavax expects a response to the same from the EMA in the first quarter of 2014.

EMA approval doesn't help a bio too much in the long run (see "dcth") but it will make people buy as it leads one to believe it has a better chance with the FDA.
 

loki

Pro
Joined
May 3, 2012
Messages
606
Reputation
1,640
Daps
690
Reppin
#Byrdgang
In my opinon yes. I would those April $1 calls for .50 are the way to go. It's not going to an exciting stock to own, as its been trading sideways. But I expect some positive catalyst to come out within 6 months.. I would like to sell some calls back at .65. Play with house money.

When would be a good time to purchase the options? Do I need to purchase a particular type?
 

ill

Superstar
Joined
May 2, 2012
Messages
10,234
Reputation
452
Daps
17,295
Reppin
Mother Russia & Greater Israel
When would be a good time to purchase the options? Do I need to purchase a particular type?

If you don't know what options are you most likely should not touch them. Also I wouldn't recommend buying bio stocks if you are a newbie. They trade different than the rest of the market and are extremely volatile.
 

Scientific Playa

Superstar
Supporter
Joined
Oct 13, 2013
Messages
13,930
Reputation
3,255
Daps
24,889
Reppin
Championships
Full disclosure, I own some shares in one of these companies and have previously invested in others mentioned in the article. No pump & dump post here.
Funny, Bush was supposed to be the free-market business president and nearly had a global meltdown while the Obama administration can boast of making these blue-chip firm's pension funds solid again. Money talks and y'all know the other part.




October 20, 2013 5:17 am

US corporate defined benefit pensions gain some lift
By Ellen Kelleher

23c7267e-dea3-482e-a501-6f8ae486145f.img


Retailer JC Penney offered lump-sum payments to former employees with vested stakes in its DB scheme

Funding levels of defined benefit pension schemes at IBM, General Motors, Ford, Boeing and other blue-chip companies in the US have experienced a welcome improvement in the past year, prompting some schemes to start taking risk off the table.

Funding ratios for the 100 largest DB pension plans at US companies, which boast close to $1.4tn in combined assets, rose to an eye-catching 91.4 per cent last month, having climbed from just 74 per cent in September 2012, according to Milliman, the actuarial firm. The improvement was largely due to shifting projections for interest rates, changes in strategy and stronger investment returns.

It marks the highest funding ratio for US DB schemes since the collapse of Lehman Brothers in October 2008.


This process may have further to run. Actuaries at Milliman forecast that pension managers at the aforementioned 100 US companies will see their funding ratios rise to an impressive 98.1 per cent by the close of next year. Their deficits should drop from $132bn at the end of September to as little as $29bn over the same period, Milliman predicts.

John Ehrhardt, a principal and consulting actuary at Milliman, explains: “As interest rates come up, it will reduce the cost of maintaining these plans.”

He adds: “If the Federal Reserve takes its foot off the floor on interest rates, rates could go up significantly.

“Generally, rising interest rates are good news for pension fund schemes because liabilities will go down as interest rates go up. But the more longer-duration bonds pension funds hold, the less of that good news they’ll see. That’s the big story for 2014.”

This burst of rosy news arrives at a time when US DB schemes are largely closed to new members as companies shift the burden of pension planning to employees by offering 401(k) plans – which are roughly equivalent to defined contribution programmes in Europe – in lieu of DB schemes.

However, there are a number of corporate stalwarts in the US whose DB plans are still open to further accrual by existing members, such as Boeing (which has a pension funding ratio of roughly 74 per cent), General Electric (70.6 per cent), AT&T (76.5 per cent), Lockheed Martin (67.2 per cent), ExxonMobil (63.4 per cent), UPS (78.1 per cent), Pfizer (71.8 per cent), Johnson & Johnson (80.3 per cent) and Federal Express (78.1 per cent).

Mr Ehrhardt notes that fund managers are changing their investment strategies as funding ratios improve for DB schemes. For example, to immunise the asset side of their balance sheet from further interest rate rises, more are investing in low-volatility equities or using derivatives as a hedging tool to remove some of the interest rate risk.

He also predicts that if market interest rates continue to rise, managers of “frozen” DB schemes, which are in run-off mode, will take advantage by offloading liabilities. “They’re telling me they want to get the cash in, wait for interest rates to rise and then dump the liabilities.”

Ways to offload liabilities might include making lump-sum payments to former employees enrolled in DB schemes or purchasing annuities for them.

Last year, the retailers Sears and JC Penney, as well as Pepsi, the beverage company, offered lump-sum payments to former employees with vested stakes in their DB schemes. Carmaker General Motors and Verizon, the telecommunications company, purchased annuities for their retirees. By doing so, GM, Verizon and Sears ditched more than 20 per cent of their pension liabilities, while Pepsi and JC Penney managed to rid themselves of between 5 and 10 per cent, according to analysis by actuaries.

Managers of DB schemes are also segmenting their assets into two categories: return-seeking and liability hedging, according to Russell Investments, the investment manager.

On the return-seeking side, they are taking risk off the table by moving into high-yield debt, bank loans and emerging market debt, believing these asset classes can produce “equity-like returns with lower volatility than stocks”, says Rachel Carroll, a senior analyst at the firm.

A number of pension plans are then implementing a so-called liability-responsive asset allocation schedule. This moves assets from their return-seeking portfolio into their liability hedging portfolio as their funding status improves, Ms Carroll says.

A first trigger point might come when a scheme’s funding ratio reaches 70-80 per cent. In such a case, about 5 per cent of assets might be moved into liability-hedging strategies.

“Pension plans, especially those plans that are frozen, see their risk-reward trade-off change as their funded status increases,” says Ms Carroll.

“An automated schedule is set up to transfer assets in conjunction with a rising funded status.”
 
Top